Colorectal cancer is a major public health concern in all developed countries. Despite decades of advances in the treatment and prevention of colorectal cancer, it remains the second most common cause of cancer death. However, the optimal method for early detection remains unknown and patient compliance with screening recommendations remains poor. This has led to the development of complementary strategies, such as chemoprevention to reduce morbidity and mortality from colorectal cancer. Chemoprevention is defined as the use of specific pharmacologic or nutrient agents to prevent, reverse, or inhibit the process of carcinogenesis. This review was designed to discuss the most promising agents in colorectal chemoprevention.
Similar content being viewed by others
References
To the Article
A Jemal T Murray A Samuels et al. (2003) ArticleTitleCancer statistics 2003 CA Cancer J Clin 53 5–26 Occurrence Handle12568441
ER Fearon B Vogelstein (1990) ArticleTitleA genetic model for colorectal tumorigenesis Cell 61 759–767 Occurrence Handle2188735 Occurrence Handle10.1016/0092-8674(90)90186-I Occurrence Handle1:CAS:528:DyaK3cXktlyhtrg%3D
GJ Kelloff CW Boone JA Crowell et al. (1996) ArticleTitleRisk biomarkers and current strategies for cancer. chemoprevention J Cell Biochem Suppl 25 1–14 Occurrence Handle9027592 Occurrence Handle1:STN:280:DyaK2s7nvFejtA%3D%3D
WS Atkin BC Morson J Cuzick (1992) ArticleTitleLong-term risk of colorectal cancer after excision of rectosigmoid adenomas N Engl J Med 326 658–662 Occurrence Handle1736104 Occurrence Handle1:STN:280:DyaK387ktVClsw%3D%3D Occurrence Handle10.1056/NEJM199203053261002
SJ Winawer AG Zauber MN Ho et al. (1993) ArticleTitlePrevention of colorectal cancer by colonoscopic polypectomy. The National Polyp Study Workgroup N Engl J Med 329 1977–1981 Occurrence Handle8247072 Occurrence Handle10.1056/NEJM199312303292701 Occurrence Handle1:STN:280:DyaK2c%2Fmslamug%3D%3D
MT Ruffin K Krishnan CL Rock et al. (1997) ArticleTitleSuppression of human colorectal mucosal prostaglandins: determining the lowest effective dose J Natl Cancer Inst 89 1152–1160 Occurrence Handle9262254 Occurrence Handle10.1093/jnci/89.15.1152 Occurrence Handle1:CAS:528:DyaK2sXls1Wnurc%3D
CE Eberhart RJ Coffey A Radhika FM Giaardello S Ferrenbach RN DuBois (1994) ArticleTitleUp-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas Gastroenterology 107 1183–1188 Occurrence Handle7926468 Occurrence Handle1:STN:280:DyaK2M%2FhtFamsA%3D%3D
H Sheng J Shao SC Kirkland et al. (1991) ArticleTitleInhibition of human colon cancer cell growth by selective inhibition of cyclo-oxygenase 2 J Clin Invest 99 2254–2259
SJ Shiff B Rigas (1999) ArticleTitleThe role of cyclooxygenase inhibition in the antineoplastic effects of nonsteroidal anti-inflammatory drugs J Exp Med 190 445–450 Occurrence Handle10449515 Occurrence Handle10.1084/jem.190.4.445 Occurrence Handle1:CAS:528:DyaK1MXltlarsrY%3D
Y Yamamoto MJ Yin KM Lin RB Gaynor (1999) ArticleTitleSulindac inhibits activation of the NF-kappaB pathway J Biol Chem 274 27307–27314 Occurrence Handle10480951 Occurrence Handle1:CAS:528:DyaK1MXmt1aktbc%3D
DJ Elder DE Halton A Hague C Paraskeva (1997) ArticleTitleInduction of apoptotic cell death in human colorectal carcinoma cell lines by a cyclooxygenase-2 selective nonsteroidal anti-inflammatory drug: independence from COX-2 protein expression Clin Cancer Res 2 1679–1683
G Josyln M Carlson A Thliveris et al. (1991) ArticleTitleIdentification of deletion mutations and three new genes at the familial polyposis locus Cell 66 600–613
WR Waddell RW Loughry (1983) ArticleTitleSulindac for polyposis of the colon J Surg Oncol 24 83–87 Occurrence Handle6887943 Occurrence Handle1:STN:280:DyaL3s3psF2gtQ%3D%3D
FM Giardiello SR Hamilton AJ Krush et al. (1993) ArticleTitleTreatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis N Engl J Med 328 1313–1316 Occurrence Handle8385741 Occurrence Handle10.1056/NEJM199305063281805 Occurrence Handle1:STN:280:DyaK3s3is1Sjtg%3D%3D
KP Nugent KCR Farmer AD Spigelman et al. (1993) ArticleTitleRandomized controlled trial of the effect of sulindac on duodenal and rectal polyposis and cell proliferation in patients with familial adenomatous polyposis Br J Surg 80 1618–1619 Occurrence Handle8298943 Occurrence Handle1:STN:280:DyaK2c7jtVSltQ%3D%3D
D Labayle D Fischer P Vielh et al. (1991) ArticleTitleSulindac causes regression of rectal polyps in familial adenomatous polyposis Gastroenterology 101 635–639 Occurrence Handle1650315 Occurrence Handle1:STN:280:DyaK3MzhslCjtw%3D%3D
M Cruz-Correa LM Hylind KE Romans et al. (2002) ArticleTitleLong-term treatment with sulindac in familial adenomatous polyposis: a prospective cohort study Gastroenterology 122 641–645 Occurrence Handle11874996 Occurrence Handle1:CAS:528:DC%2BD38Xit1ejtrg%3D
G Steinbach PM Lynch RK Phillips et al. (2000) ArticleTitleThe effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis N Engl J Med 342 1946–1952 Occurrence Handle10874062 Occurrence Handle10.1056/NEJM200006293422603 Occurrence Handle1:CAS:528:DC%2BD3cXltVCnu7Y%3D
MJ Thun MM Namboodiri CW Heath SuffixJr (1991) ArticleTitleAspirin use and reduced risk of fatal colon cancer N Engl J Med 325 1593–1596 Occurrence Handle1669840 Occurrence Handle1:STN:280:DyaK38%2FkvFGqtw%3D%3D Occurrence Handle10.1056/NEJM199112053252301
E Giovannucci EB Rimm MJ Stampfer GA Colditz A Ascherio AC Willet (1994) ArticleTitleAspirin use and the risk for colorectal cancer and adenoma in male health professionals Ann Intern Med 121 241–246 Occurrence Handle8037405 Occurrence Handle1:STN:280:DyaK2czhtFGgsg%3D%3D
E Giovannucci KM Egan DJ Hunter et al. (1995) ArticleTitleAspirin and the risk of colorectal cancer in women N Engl J Med 333 609–614 Occurrence Handle7637720 Occurrence Handle10.1056/NEJM199509073331001 Occurrence Handle1:CAS:528:DyaK2MXoslSgtb4%3D
W Smalley WA Ray J Daugherty et al. (1999) ArticleTitleUse of nonsteroidal anti-inflammatory drugs and incidence of colorectal cancer Arch Intern Med 159 161–166 Occurrence Handle9927099 Occurrence Handle10.1001/archinte.159.2.161 Occurrence Handle1:CAS:528:DyaK1MXhsF2rsLg%3D
RS Sandler S Halabi JA Baron et al. (2003) ArticleTitleA randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer N Engl J Med 348 883–890 Occurrence Handle12621132 Occurrence Handle1:CAS:528:DC%2BD3sXhvVOisbw%3D
JA Baron BF Cole RS Sandler et al. (2003) ArticleTitleA randomized trial of aspirin to prevent colorectal adenomas N Engl J Med 348 891–899 Occurrence Handle12621133 Occurrence Handle10.1056/NEJMoa021735 Occurrence Handle1:CAS:528:DC%2BD3sXhvVOitrw%3D
MJ Wargovich VW Eng HL Newmark WR Bruce (1983) ArticleTitleCalcium ameliorates the toxic effect of deoxycholic acid on colonic epithelium Carcinogenesis 4 1205–1207 Occurrence Handle6883640 Occurrence Handle1:CAS:528:DyaL3sXlvV2nt70%3D
T Ochsenkuhn E Bayerdorffer A Meining et al. (1999) ArticleTitleColonic mucosal proliferation is related to serum deoxycholic acid levels Cancer 85 1664–1669 Occurrence Handle10223558 Occurrence Handle1:STN:280:DyaK1M3jvVSluw%3D%3D
DL Earnest H Holubec RK Wali et al. (1994) ArticleTitleChemoprevention of azoxymethane-induced colonic carcinogenesis by supplemental dietary ursodeoxycholic acid Cancer Res 54 5071–5074 Occurrence Handle7923119 Occurrence Handle1:CAS:528:DyaK2cXmt12mtbw%3D
DS Pardi EV Loftus SuffixJr WR Kremens J Keach KD Lindor (2003) ArticleTitleUrsodeoxycholic acid as a chemopreventative agent in patients with ulcerative colitis and primary sclerosing cholangitis Gastroenterology 124 889–893 Occurrence Handle12671884 Occurrence Handle10.1053/gast.2003.50156 Occurrence Handle1:CAS:528:DC%2BD3sXjsFOjurY%3D
JE Rossouw GL Anderson RL Prentice et al. (2002) ArticleTitleRisks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial JAMA 288 321–333 Occurrence Handle12117397 Occurrence Handle1:CAS:528:DC%2BD38Xltlegs7k%3D
GL Anderson M Limacher AR Assaf et al. (2004) ArticleTitleEffects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial JAMA 29 1701–1712
EE Calle HL Miracle-McMahill MJ Thun CW Heath SuffixJr (1995) ArticleTitleEstrogen replacement therapy and risk of fatal colon cancer in a prospective cohort of postmenopausal women J Natl Cancer Inst 87 517–523 Occurrence Handle7707438 Occurrence Handle1:STN:280:DyaK2M3it1Kmug%3D%3D
F Grodstein ME Martinez EA Platz et al. (1998) ArticleTitlePostmenopausal hormone use and risk for colorectal cancer and adenoma Ann Intern Med 128 705–712 Occurrence Handle9556463 Occurrence Handle1:STN:280:DyaK1c3htlaltg%3D%3D
F Grodstein PA Newcomb MJ Stamfer (1999) ArticleTitlePostmenopausal hormone therapy and the risk of colorectal cancer: a review and meta-analysis Am J Med 106 574–582 Occurrence Handle10335731 Occurrence Handle10.1016/S0002-9343(99)00063-7 Occurrence Handle1:STN:280:DyaK1M3ms1OlsA%3D%3D
SH Saydah EA Platz N Rifai MN Pollak FL Brancati KJ Helzsouer (2003) ArticleTitleAssociation of markers of insulin and glucose control with subsequent colorectal cancer risk Cancer Epidemiol Biomarkers Prev 12 412–418 Occurrence Handle12750235 Occurrence Handle1:CAS:528:DC%2BD3sXjsleitLo%3D
D Witte M Chirala A Younes Y Li M Younes (2001) ArticleTitleEstrogen receptor beta is expressed in human colorectal adenocarcinoma Hum Pathol 32 940–944 Occurrence Handle11567223 Occurrence Handle10.1053/hupa.2001.27117 Occurrence Handle1:CAS:528:DC%2BD3MXnslSlt7s%3D
JA Baron M Beach JS Mandel et al. (1999) ArticleTitleCalcium supplements for the prevention of colorectal adenomas. Calcium Polyp Prevention Study Group N Engl J Med 340 101–107 Occurrence Handle9887161 Occurrence Handle1:STN:280:DyaK1M%2FptFSqtg%3D%3D
M Lipkin H Newmark (1985) ArticleTitleEffect of added dietary calcium on colonic epithelial-cell proliferation in subjects at high risk for familial colonic cancer N Engl J Med 313 1381–1384 Occurrence Handle4058532 Occurrence Handle1:STN:280:DyaL28%2FktVarsw%3D%3D Occurrence Handle10.1056/NEJM198511283132203
CB Kopp O Kronberg A Giacosa et al. (2000) ArticleTitleCalcium and fibre supplementation in prevention of colorectal adenoma recurrence: a randomized intervention trial. European Cancer Prevention Organization Study Group Lancet 356 1300–1306
CF Garland FC Garland ED Gorham (1999) ArticleTitleCalcium and vitamin D. Their potential roles in colon and breast cancer prevention Ann N Y Acad Sci 889 107–119 Occurrence Handle10668487 Occurrence Handle1:CAS:528:DC%2BD3cXnt1SmsA%3D%3D
ML McCullough AS Robertson C Rodriguez et al. (2003) ArticleTitleCalcium, vitamin D, dairy products, and risk of colorectal cancer in the Cancer Prevention Study II Nutrition Cohort Cancer Causes Control 14 1–12 Occurrence Handle12708719
PR Holt N Arber B Halmos et al. (2002) ArticleTitleColonic epithelial cell proliferation decreases with increasing levels of serum 25-hydroxy vitamin D Cancer Epidemiol Biomarkers Prev 11 113–119 Occurrence Handle11815408 Occurrence Handle1:CAS:528:DC%2BD38XhvFGitbc%3D
GJ Bemd ParticleVan den GT Chang (2002) ArticleTitleVitamin D and vitamin D analogs in cancer treatment Curr Drug Targets 3 85–94 Occurrence Handle11899952
E Giovannucci MJ Stampfer GA Colditz et al. (1993) ArticleTitleFolate, methionine, and alcohol intake and risk of colorectal adenoma J Natl Cancer Inst 85 875–884 Occurrence Handle8492316 Occurrence Handle1:STN:280:DyaK3s3mtVOhsA%3D%3D
SW Choi JB Mason (2000) ArticleTitleFolate and carcinogenesis: an integrated scheme J Nutr 130 129–132 Occurrence Handle10720158 Occurrence Handle1:CAS:528:DC%2BD3cXhtVSmsbg%3D
YJ Surh LR Ferguson (2003) ArticleTitleDietary and medicinal antimutagens and anticarcinogens: molecular mechanisms and chemopreventative potential-highlights of a symposium Mutat Res 523–524 1–8 Occurrence Handle12628498
G Biasco GM Paganelli G Brandi et al. (1992) ArticleTitleChemoprevention of colorectal cancer: role of antioxidant vitamins Eur J Cancer Prev 1 82–91
E Giovannucci MJ Stampfer GA Colditz et al. (1998) ArticleTitleMultivitamin use, folate, and colon cancer in women in the Nurses' Health Study Ann Intern Med 129 517–524 Occurrence Handle9758570 Occurrence Handle1:CAS:528:DyaK1cXmslWntL4%3D
N Malila J Virtamo M Virtanen D Albanes JA Tangrea JK Hutunen (1999) ArticleTitleThe effect of alpha-tocopherol and beta-carotene supplementation on colorectal adenomas in middle-aged smokers Cancer Epidemiol Biomarkers Prev 8 489–493 Occurrence Handle10385137 Occurrence Handle1:CAS:528:DyaK1MXkt1Cmu7Y%3D
CH Hennekens JE Buring JE Manson et al. (1996) ArticleTitleLack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease N Engl J Med 334 1145–1149 Occurrence Handle8602179 Occurrence Handle10.1056/NEJM199605023341801 Occurrence Handle1:CAS:528:DyaK28XjtVyqsLo%3D
N Albanes N Malila PR Taylor et al. (2000) ArticleTitleEffects of α-tocopherol and β-carotene on colorectal cancer: results from a controlled trial (Finland) Cancer Causes Control 11 197–203 Occurrence Handle10782653 Occurrence Handle10.1023/A:1008936214087 Occurrence Handle1:STN:280:DC%2BD3c3kt1OntQ%3D%3D
Y Feng JW Finley CD Davis et al. (1999) ArticleTitleDietary selenium reduces the formation of aberrant crypts in rats administered 3,2'-dimethyl-4-aminobiphenyl Toxicol Appl Pharmacol 157 36–42 Occurrence Handle10329505 Occurrence Handle10.1006/taap.1999.8623 Occurrence Handle1:CAS:528:DyaK1MXjtVSjtLc%3D
CV Rao I Cooma JG Rodriguez et al. (2000) ArticleTitleChemoprevention of familial adenomatous polyposis development in the APCmin mouse model by 1,4-phenylene bis(methylene)slelenocyanate Carcinogenesis 21 617–621 Occurrence Handle10753194 Occurrence Handle10.1093/carcin/21.4.617 Occurrence Handle1:CAS:528:DC%2BD3cXivFKktLs%3D
YR Seo MR Kelley ML Smith (2002) ArticleTitleSelenomethionine regulation of p53 by a ref1-dependent redox mechanism Proc Natl Acad Sci 99 IssueID14 548–553
LC Clark GF Coombs SuffixJr BW Turnbull et al. (1996) ArticleTitleEffects of selenium supplementation for cancer prevention in patients with carcinoma of the skin JAMA 276 1957–1963 Occurrence Handle8971064 Occurrence Handle10.1001/jama.276.24.1957 Occurrence Handle1:CAS:528:DyaK2sXks1eksg%3D%3D
CS Fuchs EL Giovannucci GA Colditz et al. (1999) ArticleTitleDietary fiber and the risk of colorectal cancer and adenoma in women N Engl J Med 340 169–172 Occurrence Handle9895396 Occurrence Handle10.1056/NEJM199901213400301 Occurrence Handle1:STN:280:DyaK1M7gtFylsA%3D%3D
A Schatzkin E Lanza D Corle et al. (2000) ArticleTitleLack of effect of a low-fat, high fiber diet on the recurrence of colorectal adenomas N Engl J Med 342 1149–1155 Occurrence Handle10770979 Occurrence Handle10.1056/NEJM200004203421601 Occurrence Handle1:STN:280:DC%2BD3c3hvVKjsg%3D%3D
SA Bingham NE Day R Luben et al. (2003) ArticleTitleDietary fibre in food and protection against colorectal cancer in the European Prospective Investigation into Cancer and Nutrition: an observational study Lancet 361 1496–1591 Occurrence Handle12737858 Occurrence Handle10.1016/S0140-6736(03)13174-1
To the Invited Commentary
A Ferrandez JA DiSario (2003) ArticleTitleColorectal cancer: screening and surveillance for high-risk individuals Expert Rev Anticancer Ther 3 851–862 Occurrence Handle14686707 Occurrence Handle10.1586/14737140.3.6.851
ME Martinez (2005) ArticleTitlePrimary prevention of colorectal cancer: lifestyle, nutrition, exercise Recent Results Cancer Res 166 177–211 Occurrence Handle15648191 Occurrence Handle1:CAS:528:DC%2BD2MXos1Wisw%3D%3D
A Jemal RC Tiwari T Murray et al. (2004) ArticleTitleCancer statistics, 2004 CA Cancer J Clin 54 8–29 Occurrence Handle14974761 Occurrence Handle10.3322/canjclin.54.1.8
L Nie W Feng R Diaz MA Gratton KJ Doyle EN Yamoah (2005) ArticleTitleFunctional consequences of polyamine synthesis inhibition by L-alpha-difluoromethylornithine (DFMO): cellular mechanisms for DFMO-mediated ototoxicity J Biol Chem 280 15097–15102 Occurrence Handle15718247 Occurrence Handle10.1074/jbc.M409856200 Occurrence Handle1:CAS:528:DC%2BD2MXjtFSlsbk%3D
RS Bresalier RS Sandler H Quan et al. (2005) ArticleTitleCardiovascular events associated with rofecoxib in a colorectal adenoma chemoprevention trial N Engl J Med 352 1092–1102 Occurrence Handle15713943 Occurrence Handle10.1056/NEJMoa050493 Occurrence Handle1:CAS:528:DC%2BD2MXit1Kqu7o%3D
SD Solomon JJ McMurray MA Pfeffer et al. (2005) ArticleTitleCardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention N Engl J Med 352 1071–1080 Occurrence Handle15713944 Occurrence Handle1:CAS:528:DC%2BD2MXit1Kqur4%3D
I Heiskanen HJ Jarvinen (1997) ArticleTitleFate of the rectal stump after colectomy and ileorectal anastomosis for familial adenomatous polyposis Int J Colorectal Dis 12 9–13 Occurrence Handle9112143 Occurrence Handle10.1007/s003840050070 Occurrence Handle1:STN:280:DyaK2s3ms1enuw%3D%3D
G Steinbach PM Lynch RK Phillips et al. (2000) ArticleTitleThe effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial adenomatous polyposis N Engl J Med 342 1946–1952 Occurrence Handle10874062 Occurrence Handle10.1056/NEJM200006293422603 Occurrence Handle1:CAS:528:DC%2BD3cXltVCnu7Y%3D
FM Giardiello SR Hamilton AJ Krush et al. (1993) ArticleTitleTreatment of colonic and rectal adenomas with sulindac in familial adenomatous polyposis N Engl J Med 328 1313–1316 Occurrence Handle8385741 Occurrence Handle10.1056/NEJM199305063281805 Occurrence Handle1:STN:280:DyaK3s3is1Sjtg%3D%3D
F Tonelli R Valanzano L Messerini F Ficari (2000) ArticleTitleLong-term treatment with sulindac in familial adenomatous polyposis: is there an actual efficacy in prevention of rectal cancer? J Surg Oncol 74 15–20 Occurrence Handle10861602 Occurrence Handle10.1002/1096-9098(200005)74:1<15::AID-JSO4>3.0.CO;2-Z Occurrence Handle1:CAS:528:DC%2BD3cXksVCrurk%3D
M Cruz-Correa LM Hylind KE Romans SV Booker FM Giardiello (2002) ArticleTitleLong-term treatment with sulindac in familial adenomatous polyposis: a prospective cohort study Gastroenterology 122 641–645 Occurrence Handle11874996 Occurrence Handle1:CAS:528:DC%2BD38Xit1ejtrg%3D
MH Davidson PP Toth (2004) ArticleTitleComparative effects of lipid-lowering therapies Prog Cardiovasc Dis 47 73–104 Occurrence Handle15586350 Occurrence Handle1:CAS:528:DC%2BD2MXhtVejtL8%3D Occurrence Handle10.1016/j.pcad.2004.04.007
Author information
Authors and Affiliations
Corresponding author
Additional information
Supported by grants from the NIH K07 CA092445, The Cancer Research Prevention Foundation, and The Eleanor Naylor Dana Charitable Trust.
About this article
Cite this article
Raju, R., Cruz-Correa, M. Chemoprevention of Colorectal Cancer. Dis Colon Rectum 49, 113–125 (2006). https://doi.org/10.1007/s10350-005-0170-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10350-005-0170-1